Polyzystisches Ovar-Syndrom (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Polyzystisches Ovar-Syndrom" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
2,650th place
1,472nd place
2,393rd place
2,660th place
4,464th place
5,305th place
222nd place
272nd place
low place
low place

doi.org

  • Tommaso Falcone: Androgen Response to Endogenous Insulin Secretion during the Frequently Sampled Intravenous Glucose Tolerance Test in Normal and Hyperandrogenic Women. In: The Journal of Clinical Endocrinology & Metabolism. 1. Dezember 1990, doi:10.1210/jcem-71-6-1653.
  • Paolo Giacobini: Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. In: Nature. 14. Mai 2018, doi:10.1038/s41591-018-0035-5.
  • Daniela Jakubowicz, Maayan Barnea, Julio Wainstein, Oren Froy: High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. In: Obesity (Silver Spring). Band 12, Nr. 12, Dezember 2013, S. 2504–2512, doi:10.1002/oby.20460, PMID 23512957 (wiley.com).
  • A. L. Rocha u. a.: Recent advances in the understanding and management of polycystic ovary syndrome. In: F1000. 26. April 2019, doi:10.12688/f1000research.15318.1, PMID 31069057.
  • L. Mannerås-Holm, E, Stener-Victorin u. a.: Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. In: The Journal of clinical endocrinology and metabolism. Band 96, Nummer 4, April 2011, S. 1068–1076, doi:10.1210/jc.2010-2279. PMID 21252248.
  • Kyriaki Kosidou u. a.: Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: A population-based nationwide study in Sweden. In: Molecular Psychiatry. Band 21, Nr. 10, S. 1441–1448. Online: 8. Dezember 2015, doi:10.1038/MP.2015.183
  • N. F. Goodman u. a.: American Association of Clinical Endicronologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of Polycistic ovary syndrome – Part 1. In: Endocr Pract. Band 11, 21. November 2015, S. 1291–1300, doi:10.4158/EP15748.DSC, PMID 26509855.
  • N. F. Goodman u. a.: American Association of Clinical Endicronologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of Polycistic ovary syndrome – Part 2. In: Endocr Pract. Band 21, 21. Dezember 2015, S. 1415–1426, doi:10.4158/EP15748.DSCPT2, PMID 26642102.
  • R. S. Legro, S. A. Arslanian u. a.: Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. In: The Journal of clinical endocrinology and metabolism. Band 98, Nr. 12, Dezember 2013, S. 4565–4592, doi:10.1210/jc.2013-2350, PMID 24151290, PMC 5399492 (freier Volltext).
  • V. Unfer, J. E. Nestler, Z. A. Kamenov, N. Prapas, F. Facchinett: Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. In: International Journal of Endocrinology. Band 2016, 2016, S. 1849162, doi:10.1155/2016/1849162, PMID 27843451, PMC 5097808 (freier Volltext).
  • Alice Guarano, Anna Capozzi, Martina Cristodoro, Nicoletta Di Simone, Stefano Lello,: Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth? In: Nutrients. Band 15, Nr. 14, 19. Juli 2023, S. 3209, doi:10.3390/nu15143209, PMID 37513627, PMC 10386153 (freier Volltext).
  • Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E Nestler, Christophe O Soulage: Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. In: Trends Endocrinol Metab. Band 31, Nr. 6, Juni 2020, S. 435–447, doi:10.1016/j.tem.2020.02.002, PMID 32396844. Abschnitt „Inositol Resistance“, S. 444–445.
  • Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine, Rene Druckman: Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. In: Horm Mol Biol Clin Investig. Band 34, Nr. 2, 2. März 2018, doi:10.1515/hmbci-2017-0067, PMID 29498933.
  • D. Menichini, F. Facchinetti: Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. In: Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology. Band 36, Nr. 1, Januar 2020, S. 1–5, doi:10.1080/09513590.2019.1625881, PMID 31187648.
  • C. Y. Miao, X. J. Fang, Y. Chen, Q. Zhang: Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis. In: Experimental and Therapeutic Medicine. Band 19, Nr. 4, April 2020, S. 2641–2649, doi:10.3892/etm.2020.8525, PMID 32256745, PMC 7086222 (freier Volltext).
  • Paul Grant: Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. In: Phytotherapy Research. Band 24, Nr. 2, Februar 2010, S. 186–188, doi:10.1002/ptr.2900, PMID 19585478.

jamanetwork.com

  • Francisco Álvarez-Blasco, José I. Botella-Carretero, José L. San Millán, Héctor F. Escobar-Morreale: Prevalence and Characteristics of the Polycystic Ovary Syndrome in Overweight and Obese Women. In: Arch Intern Med. Band 166, Nr. 19, 23. Oct 2006, S. 2081–2086. PMID 17060537 (Volltext)

ndnr.com

nih.gov

ncbi.nlm.nih.gov

  • Francisco Álvarez-Blasco, José I. Botella-Carretero, José L. San Millán, Héctor F. Escobar-Morreale: Prevalence and Characteristics of the Polycystic Ovary Syndrome in Overweight and Obese Women. In: Arch Intern Med. Band 166, Nr. 19, 23. Oct 2006, S. 2081–2086. PMID 17060537 (Volltext)
  • F. R. Day, J. R. Perry u. a.: Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. In: Nature. Band 6, Nr. 8464, September 2015, PMID 26416764, PMC 4598835 (freier Volltext).
  • Daniela Jakubowicz, Maayan Barnea, Julio Wainstein, Oren Froy: High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. In: Obesity (Silver Spring). Band 12, Nr. 12, Dezember 2013, S. 2504–2512, doi:10.1002/oby.20460, PMID 23512957 (wiley.com).
  • A. L. Rocha u. a.: Recent advances in the understanding and management of polycystic ovary syndrome. In: F1000. 26. April 2019, doi:10.12688/f1000research.15318.1, PMID 31069057.
  • L. Mannerås-Holm, E, Stener-Victorin u. a.: Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. In: The Journal of clinical endocrinology and metabolism. Band 96, Nummer 4, April 2011, S. 1068–1076, doi:10.1210/jc.2010-2279. PMID 21252248.
  • D. Glintborg: Endocrine and metabolic characteristics in polycystic ovary syndrome. In: Danish Medical Journal. Band 63, Nr. 4, April 2016, PMID 27034186.
  • N. F. Goodman u. a.: American Association of Clinical Endicronologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of Polycistic ovary syndrome – Part 1. In: Endocr Pract. Band 11, 21. November 2015, S. 1291–1300, doi:10.4158/EP15748.DSC, PMID 26509855.
  • N. F. Goodman u. a.: American Association of Clinical Endicronologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of Polycistic ovary syndrome – Part 2. In: Endocr Pract. Band 21, 21. Dezember 2015, S. 1415–1426, doi:10.4158/EP15748.DSCPT2, PMID 26642102.
  • R. S. Legro, S. A. Arslanian u. a.: Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. In: The Journal of clinical endocrinology and metabolism. Band 98, Nr. 12, Dezember 2013, S. 4565–4592, doi:10.1210/jc.2013-2350, PMID 24151290, PMC 5399492 (freier Volltext).
  • V. Unfer, J. E. Nestler, Z. A. Kamenov, N. Prapas, F. Facchinett: Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. In: International Journal of Endocrinology. Band 2016, 2016, S. 1849162, doi:10.1155/2016/1849162, PMID 27843451, PMC 5097808 (freier Volltext).
  • Asieh Mansour, Saeed Hosseini, Bagher Larijani, Mohammad Reza Mohajeri-Tehrani: Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. In: EXCLI Journal Experimental and Clinical Sciences. September 2016, PMID 28096785, PMC 5225686 (freier Volltext).
  • Alice Guarano, Anna Capozzi, Martina Cristodoro, Nicoletta Di Simone, Stefano Lello,: Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth? In: Nutrients. Band 15, Nr. 14, 19. Juli 2023, S. 3209, doi:10.3390/nu15143209, PMID 37513627, PMC 10386153 (freier Volltext).
  • Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E Nestler, Christophe O Soulage: Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. In: Trends Endocrinol Metab. Band 31, Nr. 6, Juni 2020, S. 435–447, doi:10.1016/j.tem.2020.02.002, PMID 32396844. Abschnitt „Inositol Resistance“, S. 444–445.
  • Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine, Rene Druckman: Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. In: Horm Mol Biol Clin Investig. Band 34, Nr. 2, 2. März 2018, doi:10.1515/hmbci-2017-0067, PMID 29498933.
  • Ming-Wei Lin, Meng-Hsing Wu: The role of vitamin D in polycystic ovary syndrome. In: Indian Journal of Medical Research. September 2015, PMC 4669857 (freier Volltext).
  • D. Menichini, F. Facchinetti: Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. In: Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology. Band 36, Nr. 1, Januar 2020, S. 1–5, doi:10.1080/09513590.2019.1625881, PMID 31187648.
  • C. Y. Miao, X. J. Fang, Y. Chen, Q. Zhang: Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis. In: Experimental and Therapeutic Medicine. Band 19, Nr. 4, April 2020, S. 2641–2649, doi:10.3892/etm.2020.8525, PMID 32256745, PMC 7086222 (freier Volltext).
  • Paul Grant: Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. In: Phytotherapy Research. Band 24, Nr. 2, Februar 2010, S. 186–188, doi:10.1002/ptr.2900, PMID 19585478.
  • A. Karkanaki, C. Vosnakis, D. Panidis: The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology. In: Hormones (Athens). Band 10, Nummer 2, April–Juni 2011, S. 95–103. PMID 21724534.
  • B. O. Saleh, W. F. Ibraheem, N. S. Ameen: The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome. In: Saudi Med J. Band 36, Nummer 5, Mai 2015, S. 562–567. PMID 25935176.
  • B. O. Saleh, W. F. Ibraheem, N. S. Ameen: Anti-Műllerian hormone--a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome. In: J Med Life. Band 5, Nr. 4, Dezember 2012, S. 462–464, PMID 23346251, PMC 3539844 (freier Volltext).
  • E. Stener-Victorin, E. Jedel, L. Mannerås: Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence. In: J Neuroendocrinol. 28. November 2007. PMID 18047551
  • E. H. Ng, W. S. So, J. Gao, Y. Y. Wong, P. C. Ho: The role of acupuncture in the management of subfertility. In: Fertil Steril. Band 90, Nr. 1, Jul 2008, S. 1–13. Epub 2008 Apr 28. PMID 18440533

tau.ac.il

english.tau.ac.il

thelancet.com

  • Robert J. Norman, Didier Dewailly, Richard S. Legro, Theresa E. Hickey: Seminar: Polycystic ovary syndrome. In: The Lancet. Band 370, 2007, S. 685–697. (Zusammenfassung)

wiley.com

onlinelibrary.wiley.com

  • Daniela Jakubowicz, Maayan Barnea, Julio Wainstein, Oren Froy: High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. In: Obesity (Silver Spring). Band 12, Nr. 12, Dezember 2013, S. 2504–2512, doi:10.1002/oby.20460, PMID 23512957 (wiley.com).